Bausch + Lomb Corp
NYSE:BLCO
Operating Margin
Bausch + Lomb Corp
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
4.1B USD |
3%
|
|
| CH |
|
Alcon AG
SIX:ALC
|
34.7B CHF |
14%
|
|
| JP |
|
Hoya Corp
TSE:7741
|
5.8T JPY |
29%
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
138.1B DKK |
27%
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.3B USD |
16%
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5.8B GBP |
15%
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
5.5B CHF |
15%
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
45.6B CNY |
43%
|
|
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
5.4B USD |
12%
|
|
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.5B USD |
29%
|
|
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
7T KRW |
-149%
|
Bausch + Lomb Corp
Glance View
Founded in 1853, Bausch + Lomb Corp. began as a small optical goods store in Rochester, New York, eventually blossoming into a multinational eye health business. Over its long history, the company has established itself as a cornerstone in the realm of vision care, leveraging its deep expertise to innovate and expand its product offerings. Today, Bausch + Lomb operates through three primary business segments: Vision Care, Ophthalmic Pharmaceuticals, and Surgical. In the Vision Care segment, it provides contact lenses, lens care products, and other related items, making it a trusted choice for consumers around the globe. The Ophthalmic Pharmaceuticals division addresses a broad spectrum of eye health needs, producing prescription and over-the-counter pharmaceuticals that target various eye conditions. Meanwhile, the Surgical segment offers a suite of ophthalmic surgical devices, designed for procedures ranging from cataract extraction to vitreoretinal surgery. Bausch + Lomb generates revenue through a mix of consumer products and medical equipment. Their extensive contact lens product line caters to diverse needs – from daily disposables to specialized lenses for specific eye conditions, thereby capturing a significant portion of the eye care market. The company's pharmaceuticals and surgical tools not only complement its vision care products but also tap into the lucrative medical market, providing solutions for both medical professionals and their patients. By maintaining a robust portfolio that spans consumer goods and professional-grade equipment, Bausch + Lomb effectively positions itself as both a retail and medical partner, ensuring steady revenue streams from a global customer base. With a blend of research-driven innovation and strategic market positioning, Bausch + Lomb continues to cement its legacy as a leader in eye health.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Bausch + Lomb Corp's most recent financial statements, the company has Operating Margin of 2.6%.
You don't have any saved screeners yet